| Kaiser Foundation Health Plan Northern California |
| Tagrisso (osimertinib) |
| Drugs for Cancer : Drugs for Cancer |
- Overactive Bladder:
Duration: 1 year(s)
Documented Diagnosis: Yes
Medical Test Required: No
Reauthorization Required: No
Duration of Reauthorization: N/A
- Prior Authorization: PA Required
|